Glimepiride

Product NDC: 55111-320
11-digit product format: 551110320
Labeler code: 55111
Product ID: 55111-320_e3d50334-9896-b2f9-a481-8383eb84b16a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glimepiride
Dosage form: TABLET
Route: ORAL
Labeler: Dr. Reddy's Laboratories Limited
Application: ANDA077091
Marketing category: ANDA
Marketing start: 2005-10-06
Substance: GLIMEPIRIDE
Active strength: 1 mg/1
Pharmacologic classes: Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077091-001	GLIMEPIRIDE	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	RS	2005-10-06
A077091-002	GLIMEPIRIDE	GLIMEPIRIDE	2MG	TABLET / ORAL	AB		2005-10-06
A077091-003	GLIMEPIRIDE	GLIMEPIRIDE	4MG	TABLET / ORAL	AB		2005-10-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A077091-001	AB
A077091-002	AB
A077091-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A077091-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	RS	2005-10-06	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A077091-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB		2005-10-06	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A077091-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB		2005-10-06	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A077091-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A077091-002	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A077091-003	AB	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glimepiride	GLIMEPIRIDE	Cardinal Health 107, LLC	cc2bc07f-3fab-4df1-85cc-dc0c8e60b4fa	2026-05-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	NuCare Pharmaceuticals,Inc.	bf8e5993-5ee7-d26d-e053-2a95a90ae5df	2026-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	AvPAK	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	2026-01-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	Northwind Health Company, LLC	f3184cd3-df99-db32-e053-2995a90aa573	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	Northwind Health Company, LLC	dae404ac-881a-14d8-e053-2995a90acd41	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	101cdc41-2131-4425-b550-6a0a60b5f4a4	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	657f1b51-2f82-44f6-a23d-97f4b34b3c45	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	American Health Packaging	0003458f-352a-46fa-9d99-230daa76ae29	2024-11-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	Proficient Rx LP	1f102e4c-1954-4f17-8c60-4dad79f25a25	2024-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	NuCare Pharmaceuticals,Inc.	abc187f1-8645-23e9-e053-2a95a90a64a7	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	A-S Medication Solutions	be772fca-1579-4fba-a4b7-04b970d09e45	2023-12-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	A-S Medication Solutions	0a1eaf23-d5fd-4b3e-96c5-68ff16f0033b	2023-12-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	A-S Medication Solutions	a9461830-1c4f-4bc4-b622-1c44112a76b9	2023-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	A-S Medication Solutions	def20e38-01f7-4ead-beb6-3dc11062a342	2023-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	Bryant Ranch Prepack	ebb9f080-b11d-5d18-36f0-627107e7fbcd	2020-08-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091
Glimepiride	GLIMEPIRIDE	Dr. Reddy's Laboratories Limited	07ad4366-4b21-f633-49f3-c2b35f88168d	2019-01-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077091 application number: ANDA077091 ndc (product): 55111-320

Additional Listing Data#

Finished product: Yes
Brand name base: Glimepiride
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GLIMEPIRIDE	1 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6KY687524K	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
199245	Internal RxNorm lookup
199246	Internal RxNorm lookup
199247	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
07ad4366-4b21-f633-49f3-c2b35f88168d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b890b964-2cf0-4439-aaf3-900c9e3e9e49	Product name	1	20160602
7611093e-8875-33d4-9e3c-f48c7e3af1e8	Product name	1	20140508
d36d861f-8a90-80cc-8935-1e6be9b4c7eb	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
55111-320-01	Glimepiride	100 in 1 BOTTLE	TABLET	100	12
55111-320-05	Glimepiride	500 in 1 BOTTLE	TABLET	500	12
55111-320-30	Glimepiride	30 in 1 BOTTLE	TABLET	30	12
55111-320-78	Glimepiride	100 in 1 CARTON	TABLET	100	12
55111-320-79	Glimepiride	1 in 1 BLISTER PACK	TABLET	1	12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55111-320-01	EA - Each	55111-320	107e9e7b-88fa-4288-9932-960958715310	1	2012-07-24
55111-320-05	EA - Each	55111-320	518a4018-d2c6-4f2d-8e37-3f31a0d2cac8	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLIMEPIRIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	10
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
Povidone	INACTIVE INGREDIENT	FZ989GH94E	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	7
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
povidone	INACTIVE INGREDIENT	FZ989GH94E	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLIMEPIRIDE (GLIMEPIRIDE ) TABLET [PD-RX PHARMACEUTICALS, INC.]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLIMEPIRIDE TABLET [AMERICAN HEALTH PACKAGING]	3
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
povidone	INACTIVE INGREDIENT	FZ989GH94E	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLIMEPIRIDE TABLET [REBEL DISTRIBUTORS CORP]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55111-320	GLIMEPIRIDE TABLET [DR. REDDY'S LABORATORIES LIMITED]	12	Current NDC, Legacy NDC, 5 package rows	20190130_07ad4366-4b21-f633-49f3-c2b35f88168d.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6KY687524K	GLIMEPIRIDE	93479-97-1	GLIMEPIRIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199245	glimepiride 1 MG Oral Tablet	PSN	43852c05-e091-4758-aac1-1bb3aa515b7e	100
199245	glimepiride 1 MG Oral Tablet	SCD	43852c05-e091-4758-aac1-1bb3aa515b7e	100
199245	glimepiride 1 MG Oral Tablet	PSN	657f1b51-2f82-44f6-a23d-97f4b34b3c45	21
199245	glimepiride 1 MG Oral Tablet	SCD	657f1b51-2f82-44f6-a23d-97f4b34b3c45	21
199245	glimepiride 1 MG Oral Tablet	PSN	07ad4366-4b21-f633-49f3-c2b35f88168d	12
199246	glimepiride 2 MG Oral Tablet	PSN	07ad4366-4b21-f633-49f3-c2b35f88168d	12
199247	glimepiride 4 MG Oral Tablet	PSN	07ad4366-4b21-f633-49f3-c2b35f88168d	12
199245	glimepiride 1 MG Oral Tablet	SCD	07ad4366-4b21-f633-49f3-c2b35f88168d	12
199246	glimepiride 2 MG Oral Tablet	SCD	07ad4366-4b21-f633-49f3-c2b35f88168d	12
199247	glimepiride 4 MG Oral Tablet	SCD	07ad4366-4b21-f633-49f3-c2b35f88168d	12
199245	glimepiride 1 MG Oral Tablet	PSN	0003458f-352a-46fa-9d99-230daa76ae29	11
199246	glimepiride 2 MG Oral Tablet	PSN	0003458f-352a-46fa-9d99-230daa76ae29	11
199247	glimepiride 4 MG Oral Tablet	PSN	0003458f-352a-46fa-9d99-230daa76ae29	11
199245	glimepiride 1 MG Oral Tablet	SCD	0003458f-352a-46fa-9d99-230daa76ae29	11
199246	glimepiride 2 MG Oral Tablet	SCD	0003458f-352a-46fa-9d99-230daa76ae29	11
199247	glimepiride 4 MG Oral Tablet	SCD	0003458f-352a-46fa-9d99-230daa76ae29	11
199245	glimepiride 1 MG Oral Tablet	PSN	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	5
199246	glimepiride 2 MG Oral Tablet	PSN	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	5
199247	glimepiride 4 MG Oral Tablet	PSN	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	5
199245	glimepiride 1 MG Oral Tablet	SCD	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	5
199246	glimepiride 2 MG Oral Tablet	SCD	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	5
199247	glimepiride 4 MG Oral Tablet	SCD	93f1e064-fcbd-e8fd-e053-2995a90a5dbb	5
199245	glimepiride 1 MG Oral Tablet	PSN	3b20ae5e-9807-46c2-9de1-b64e76e61730	2
199246	glimepiride 2 MG Oral Tablet	PSN	3b20ae5e-9807-46c2-9de1-b64e76e61730	2
199247	glimepiride 4 MG Oral Tablet	PSN	3b20ae5e-9807-46c2-9de1-b64e76e61730	2
199245	glimepiride 1 MG Oral Tablet	SCD	3b20ae5e-9807-46c2-9de1-b64e76e61730	2
199246	glimepiride 2 MG Oral Tablet	SCD	3b20ae5e-9807-46c2-9de1-b64e76e61730	2
199247	glimepiride 4 MG Oral Tablet	SCD	3b20ae5e-9807-46c2-9de1-b64e76e61730	2
199245	glimepiride 1 MG Oral Tablet	PSN	1f102e4c-1954-4f17-8c60-4dad79f25a25	1
199245	glimepiride 1 MG Oral Tablet	SCD	1f102e4c-1954-4f17-8c60-4dad79f25a25	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55111-320-01	55111032001	100 TABLET in 1 BOTTLE (55111-320-01)	100 tablet	2005-10-06	0000-00-00	No	No	Current
55111-320-05	55111032005	500 TABLET in 1 BOTTLE (55111-320-05)	500 tablet	2005-10-06	0000-00-00	No	No	Current
55111-320-30	55111032030	30 TABLET in 1 BOTTLE (55111-320-30)	30 tablet	2005-10-06	0000-00-00	No	No	Current
55111-320-78	55111032078	100 BLISTER PACK in 1 CARTON (55111-320-78) / 1 TABLET in 1 BLISTER PACK (55111-320-79)	100 blister pack	2005-10-06	0000-00-00	No	No	Current
55111-320-79	55111032079	1 in 1 BLISTER PACK						Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glimepiride	AvPAK	2026-01-14	HUMAN PRESCRIPTION DRUG LABEL	5
Glimepiride	PD-Rx Pharmaceuticals, Inc.	2025-10-15	HUMAN PRESCRIPTION DRUG LABEL	21
Glimepiride	American Health Packaging	2024-11-13	HUMAN PRESCRIPTION DRUG LABEL	11
Glimepiride	Proficient Rx LP	2024-09-01	HUMAN PRESCRIPTION DRUG LABEL	1
Glimepiride	REMEDYREPACK INC.	2024-03-27	HUMAN PRESCRIPTION DRUG LABEL	2
Glimepiride	Bryant Ranch Prepack	2021-12-21	HUMAN PRESCRIPTION DRUG LABEL	100
Glimepiride	Bryant Ranch Prepack	2021-11-22	HUMAN PRESCRIPTION DRUG LABEL	10
Glimepiride	Dr. Reddy's Laboratories Limited \| Dr. Reddy's Laboratories Limited (FTO-III) \| DR. REDDY'S LABORATORIES LIMITED (FTO-Sez-Process Unit-01)	2019-01-16	HUMAN PRESCRIPTION DRUG LABEL	12
Glimepiride	NCS HealthCare of KY, Inc dba Vangard Labs	2013-08-26	HUMAN PRESCRIPTION DRUG LABEL	10
Glimepiride Tablets USP	Rebel Distributors Corp	2010-09-28	HUMAN PRESCRIPTION DRUG LABEL	2